FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024586585> ?p ?o ?g. }

• W3024586585 endingPage "e770" @default.
• W3024586585 startingPage "e761" @default.
• W3024586585 abstract "Introduction p53 and antiapoptotic B-cell leukemia/lymphoma 2 (BLC2) have been proposed as prognostic markers for early breast cancer (BC), although their relationship with conventional parameters and patient prognosis, as well as their distribution within the molecular BC subtypes remains uncertain. Patients and Methods In this observational study, we analyzed the immunohistochemical expression of p53 and BLC2 in 1099 early BC patients surgically treated between 2000 and 2006 and followed for at least 5 years, also considering their association with pathologic factors and molecular subtypes, as well as their influence on disease-free survival. Results p53 and BLC2 are distributed differently across molecular subtypes (P < .0001); in particular, p53 positivity and BLC2 negativity seems to be associated with more aggressive conventional tumor phenotypes. Moreover, BLC2 negativity seems to be a significant discriminating factor for disease-free survival (P = .003) according to Kaplan-Meier analysis, while p53 seems to have no discriminating effect. Among patients with discordant p53/BLC2 phenotype, the combination p53+BLC2− seems to be associated with the worst outcomes (P = .007) and significantly influenced the clinical course of node-negative patients treated only with hormone therapy (P = .004). Conclusion These two biomarkers, in addition to conventional pathologic factors and molecular subtype, could help define the risk and outcome of BC." @default.
• W3024586585 created "2020-05-21" @default.
• W3024586585 creator A5008029111 @default.
• W3024586585 creator A5019614566 @default.
• W3024586585 creator A5023710153 @default.
• W3024586585 creator A5026785056 @default.
• W3024586585 creator A5044383601 @default.
• W3024586585 creator A5050243893 @default.
• W3024586585 creator A5053241250 @default.
• W3024586585 creator A5054042910 @default.
• W3024586585 creator A5061240925 @default.
• W3024586585 creator A5072074063 @default.
• W3024586585 creator A5074002309 @default.
• W3024586585 creator A5080823945 @default.
• W3024586585 creator A5082149678 @default.
• W3024586585 creator A5082689719 @default.
• W3024586585 creator A5084919462 @default.
• W3024586585 creator A5091117889 @default.
• W3024586585 date "2020-12-01" @default.
• W3024586585 modified "2023-10-16" @default.
• W3024586585 title "p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study" @default.
• W3024586585 cites W1558526836 @default.
• W3024586585 cites W1964719993 @default.
• W3024586585 cites W1992087514 @default.
• W3024586585 cites W2021125112 @default.
• W3024586585 cites W2021222669 @default.
• W3024586585 cites W2028921564 @default.
• W3024586585 cites W2038302740 @default.
• W3024586585 cites W2088883749 @default.
• W3024586585 cites W2101657563 @default.
• W3024586585 cites W2105882193 @default.
• W3024586585 cites W2117775530 @default.
• W3024586585 cites W2124964909 @default.
• W3024586585 cites W2128321558 @default.
• W3024586585 cites W2129024956 @default.
• W3024586585 cites W2130639106 @default.
• W3024586585 cites W2131604549 @default.
• W3024586585 cites W2136578585 @default.
• W3024586585 cites W2155390490 @default.
• W3024586585 cites W2160377567 @default.
• W3024586585 cites W2168362647 @default.
• W3024586585 cites W2262230949 @default.
• W3024586585 cites W2267844613 @default.
• W3024586585 cites W2396909454 @default.
• W3024586585 cites W2512615678 @default.
• W3024586585 cites W2514228312 @default.
• W3024586585 cites W2517421365 @default.
• W3024586585 cites W2528031397 @default.
• W3024586585 cites W2602363134 @default.
• W3024586585 cites W2614556404 @default.
• W3024586585 cites W2617077704 @default.
• W3024586585 cites W2730231279 @default.
• W3024586585 cites W2742598198 @default.
• W3024586585 cites W2770165248 @default.
• W3024586585 cites W2805734855 @default.
• W3024586585 cites W4244788649 @default.
• W3024586585 doi "https://doi.org/10.1016/j.clbc.2020.05.005" @default.
• W3024586585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32580907" @default.
• W3024586585 hasPublicationYear "2020" @default.
• W3024586585 type Work @default.
• W3024586585 sameAs 3024586585 @default.
• W3024586585 citedByCount "4" @default.
• W3024586585 countsByYear W30245865852020 @default.
• W3024586585 countsByYear W30245865852021 @default.
• W3024586585 countsByYear W30245865852023 @default.
• W3024586585 crossrefType "journal-article" @default.
• W3024586585 hasAuthorship W3024586585A5008029111 @default.
• W3024586585 hasAuthorship W3024586585A5019614566 @default.
• W3024586585 hasAuthorship W3024586585A5023710153 @default.
• W3024586585 hasAuthorship W3024586585A5026785056 @default.
• W3024586585 hasAuthorship W3024586585A5044383601 @default.
• W3024586585 hasAuthorship W3024586585A5050243893 @default.
• W3024586585 hasAuthorship W3024586585A5053241250 @default.
• W3024586585 hasAuthorship W3024586585A5054042910 @default.
• W3024586585 hasAuthorship W3024586585A5061240925 @default.
• W3024586585 hasAuthorship W3024586585A5072074063 @default.
• W3024586585 hasAuthorship W3024586585A5074002309 @default.
• W3024586585 hasAuthorship W3024586585A5080823945 @default.
• W3024586585 hasAuthorship W3024586585A5082149678 @default.
• W3024586585 hasAuthorship W3024586585A5082689719 @default.
• W3024586585 hasAuthorship W3024586585A5084919462 @default.
• W3024586585 hasAuthorship W3024586585A5091117889 @default.
• W3024586585 hasConcept C104317684 @default.
• W3024586585 hasConcept C121608353 @default.
• W3024586585 hasConcept C126322002 @default.
• W3024586585 hasConcept C127716648 @default.
• W3024586585 hasConcept C143998085 @default.
• W3024586585 hasConcept C15744967 @default.
• W3024586585 hasConcept C204232928 @default.
• W3024586585 hasConcept C23131810 @default.
• W3024586585 hasConcept C2779134260 @default.
• W3024586585 hasConcept C530470458 @default.
• W3024586585 hasConcept C55493867 @default.
• W3024586585 hasConcept C71924100 @default.
• W3024586585 hasConcept C7453019 @default.
• W3024586585 hasConcept C77805123 @default.
• W3024586585 hasConcept C86803240 @default.
• W3024586585 hasConceptScore W3024586585C104317684 @default.

• next